Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Chronic Opioid Use May be Common in Patients With Ankylosing Spondylitis

Publish date:: July 29, 2019

Key clinical point: Chronic opioid use may be common in patients with ankylosing spondylitis.

Major finding: Of those patients given the International Classification of Diseases (ICD) code 720.0, which is specific for ankylosing spondylitis, 23.5% of patients received at least a 90-day supply of opioids in a year.

Study details: The findings were noted in 2012-2017 data from a cohort of 11,945 patients in the Truven Health MarketScan Research database.

Disclosures: UCB Pharma funded the study. The authors are employees of UCB Pharma.

Citation:

Sloan VS et al. J Rheumatol. 2019 Jan 15. doi: 10.3899/jrheum.180972.

This Week's Must Reads

Younger adults present with more advanced esophageal adenocarcinoma,

Osteoporosis prevalence in PsA similar to general population,

Annual WCC visits significantly limit asthma worsening,

U.S. mothers underestimate role breastfeeding plays in curbing breast cancer,

Microplastics permeate human placentas,

Must Reads in Opioid Resource Center

ERAS protocol for cesarean delivery reduces opioid usage,

Critical care admissions up for pediatric opioid poisonings,

Survey: Cancer-Related Pain, Opioid Use Up Since 2018,

Opioid reduction works after minimally invasive gynecologic surgery,

Opioids, Benzodiazepines Carry Greater Risk of COPD-Related Hospitalization,